New Hypoxemia and "Improving" Leg Pain in a Child With Sickle Cell Disease
Mateo is 7 years old with HbSS, admitted 36 hours ago for a vaso-occlusive pain crisis (bilateral thigh and back pain, 8/10). He is on a morphine PCA and IV fluids at 1x maintenance. Overnight he spikes to 38.9 C, respiratory rate 34, SpO2 90% on room air, and reports new right-sided chest pain. Breath sounds are diminished at the right base. Labs: Hgb 6.9 g/dL (baseline 8.5), WBC 24,000, platelets 132,000, reticulocytes 2.8% (baseline 12%). When you ask about his legs, he says the pain is "way better -- like a 2." His mother is relieved and asks whether he can go home tomorrow since he is finally improving.
1. Which findings concern you most, and how do you interpret the sudden improvement in his leg pain?
Read the worked answer
The improvement in leg pain is not reassuring in this context. Two things can make a sickle cell patient's pain score fall: adequate analgesia, or progression. Here the drop is accompanied by new chest pain, tachypnea, hypoxemia, fever, and a focal exam finding -- that pattern points to acute chest syndrome (ACS), not resolution.
Treat the falling pain score as a possible early sign of opioid effect plus a child who is now too sick or too hypoxemic to complain. Reassess pain with a consistent scale and ask about function (can he take deep breaths, sit up, drink?), not just the number.
The second red flag is the reticulocyte count falling to 2.8% from a baseline of 12% with Hgb below baseline. A reticulocytopenia in a child with a febrile illness suggests a parvovirus B19 aplastic crisis layered onto ACS, which will worsen anemia over the next several days and changes how aggressively you transfuse and how often you recheck counts.
Priority framing: this is a respiratory emergency with an anticipated worsening anemia, not a pain-control question.
2. What will you do in the first hour, and what orders will you request?
Read the worked answer
Airway/breathing first: oxygen to keep SpO2 at least 95% (per institutional target), continuous pulse oximetry, position for comfort, and prepare for escalation if work of breathing increases.
Diagnostics and cultures: blood cultures before antibiotics (do not delay antibiotics for the culture), chest radiograph, CBC with differential and reticulocyte count, type and screen/crossmatch, blood gas if worsening, and consider nasopharyngeal viral testing.
Antibiotics: broad-spectrum coverage for encapsulated organisms plus atypical coverage -- typically ceftriaxone plus a macrolide -- because ACS is driven by infection, infarction, and fat embolism and cannot be distinguished clinically at the bedside.
Transfusion readiness: notify the provider immediately. He is hypoxemic with a Hgb of 6.9, which makes him a candidate for urgent transfusion; the blood bank needs lead time for sickle-negative, extended-matched units.
Supportive care: incentive spirometry or incentive spirometer equivalent (age-appropriate blowing games) at least every 1-2 hours while awake -- this is a treatment, not a comfort measure; keep IV fluids at maintenance and resist bolusing for hypotension without reassessment, because pulmonary edema is a real risk; continue analgesia so he can breathe deeply.
What I would not do: agree to discharge planning, or increase fluids reflexively because he "looks dry."
3. The team debates simple versus exchange transfusion. What drives the choice, and what is the endpoint?
Read the worked answer
Decision logic, not a rule to memorize:
- Simple transfusion is reasonable for mild ACS, especially when the Hgb is well below the child's baseline and there is no severe hypoxemia. It is faster and available everywhere, but it adds red cell volume and raises viscosity.
- Exchange transfusion (manual or erythrocytapheresis) is favored when there is hypoxemia despite oxygen, multilobar or rapidly progressive disease, clinical deterioration on simple transfusion, or a Hgb already near normal where a simple transfusion would push viscosity too high. Exchange lowers HbS while raising oxygen-carrying capacity without volume overload.
Endpoint: a target Hgb of roughly 10-11 g/dL, and a HbS fraction under about 30% if exchange is used. Do not chase a "normal" hemoglobin -- raising Hgb above about 11-12 g/dL in sickle cell disease increases viscosity and can worsen vaso-occlusion and stroke risk. That is exactly why a child with a Hgb of 6.9 and severe hypoxemia may need exchange rather than two units of simple transfusion.
Monitoring after transfusion: recheck Hgb and HbS, watch for transfusion reaction and for hyperviscosity (headache, new neurologic symptoms), and continue respiratory support and incentive spirometry -- transfusion does not substitute for lung expansion.